Suppr超能文献

两个甲状腺激素抵抗突变体,其激素结合功能受损。

Two resistance to thyroid hormone mutants with impaired hormone binding.

作者信息

Huber B Russell, Sandler Ben, West Brian L, Cunha Lima Suzana T, Nguyen Hoa T, Apriletti James W, Baxter John D, Fletterick Robert J

机构信息

University of California, San Francisco, Department of Biochemistry Biophysics, 513 Parnassus Avenue, San Francisco, California 94143-0448, USA.

出版信息

Mol Endocrinol. 2003 Apr;17(4):643-52. doi: 10.1210/me.2002-0095. Epub 2003 Jan 16.

Abstract

Resistance to hormones is commonly due to mutations in genes encoding receptors. Resistance to thyroid hormone is due mostly to mutations of the beta-form of the human (h) thyroid hormone receptor (hTRbeta). We determined x-ray crystal structures of two hTRbeta ligand-binding domains (LBDs), Ala 317 Thr and Arg 316 His. Amino acids 316 and 317 form part of the hormone-binding pocket. The methyl of Ala 317, contacting iodine, sculpts the T3 hormone-binding pocket. Arg 316 is not in direct contact with T3 and has an unknown role in function. Remarkably, the Arg forms part of an unusual buried polar cluster in hTRbeta. Although the identity of the amino acids changes, the polar cluster appears in all nuclear receptors. In spite of the differing roles of 316 and 317, both resistance to thyroid hormone mutants display decreased T3 affinity and weakened transcriptional activation. The two mutants differ in that the Arg 316 His receptor does not form TR-TR homodimers on DNA. 3,5,3'-Triiodothyroacetic acid is bound to both receptors. Thr 317 repositions 3,5,3'-triiodothyroacetic acid distending the face of the receptor that binds coregulators. Arg 316 forms two hydrogen bonds with helix 1. Both are lost with mutation to His displacing helix 1 of the LBD and disordering the loop after helix 1. The stability of the helix 1, deriving in part from the buried polar cluster, is important for hormone binding and formation of TR dimers. The observation that the Arg 316 His mutation affects these functions implies a role for helix 1 in linking hormone binding to the DNA-binding domain-LBD configuration.

摘要

对激素的抵抗通常是由于编码受体的基因突变所致。对甲状腺激素的抵抗主要归因于人类(h)甲状腺激素受体(hTRβ)β型的突变。我们确定了两种hTRβ配体结合结构域(LBD),即丙氨酸317苏氨酸和精氨酸316组氨酸的X射线晶体结构。氨基酸316和317构成激素结合口袋的一部分。丙氨酸317的甲基与碘接触,塑造了T3激素结合口袋。精氨酸316不直接与T3接触,其在功能中的作用尚不清楚。值得注意的是,精氨酸在hTRβ中形成了一个不寻常的埋藏极性簇的一部分。尽管氨基酸的身份发生了变化,但极性簇在所有核受体中都存在。尽管316和317的作用不同,但两种甲状腺激素抵抗突变体均表现出T3亲和力降低和转录激活减弱。这两种突变体的不同之处在于,精氨酸316组氨酸受体在DNA上不形成TR-TR同二聚体。3,5,3'-三碘甲状腺乙酸与两种受体结合。苏氨酸317重新定位3,5,3'-三碘甲状腺乙酸,使结合共调节因子的受体表面扩张。精氨酸316与螺旋1形成两个氢键。突变成为组氨酸后,这两个氢键都消失了,取代了LBD的螺旋1并使螺旋1后的环无序。螺旋1的稳定性部分源于埋藏的极性簇,对激素结合和TR二聚体的形成很重要。精氨酸316组氨酸突变影响这些功能的观察结果表明,螺旋1在将激素结合与DNA结合结构域-LBD构型联系起来方面发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验